Veracyte (VCYT) Non Operating Income (2012 - 2026)

Veracyte has disclosed Non Operating Income across 15 years of filings, most recently posting $7.3 million for Q1 2026.

• Non Operating Income for Q1 2026 came in at $7.3 million, up 61.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.2 million (up 16.26% YoY), and the FY2025 annual result was $10.4 million, up 8.56% from the prior year.
• Non Operating Income came in at $7.3 million for Q1 2026 at Veracyte, up from $3.4 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $7.3 million in Q1 2026 to a low of -$4.1 million in Q3 2025.
• The 5-year median for Non Operating Income is $2.4 million (2023), against an average of $2.4 million.
• Across the five-year window, Non Operating Income soared 1319.03% in 2024 and tumbled 183.98% in 2025, its largest moves.
• Veracyte's Non Operating Income stood at $2.0 million in 2022, then jumped by 154.42% to $5.0 million in 2023, then sank by 114.54% to -$732000.0 in 2024, then soared by 569.81% to $3.4 million in 2025, then soared by 113.09% to $7.3 million in 2026.
• The last three Non Operating Income figures came in at $7.3 million (Q1 2026), $3.4 million (Q4 2025), and -$4.1 million (Q3 2025), per Business Quant data.